Bank of New York Mellon Corp
BankPosition in OTLK — Outlook Therapeutics, Inc.
CIK 1390777
NEW YORK, NY
Position in OTLK
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$29,675
-$3,659 QoQ
Shares Held
18,664
-31.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 68 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OTLK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. OTLK ranks #298 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in OTLK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,675 | 18,664 | Shares | Defined | 2026-08-06 | |
| 2025-03-31 | $33,334 | 27,324 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $56,252 | 29,764 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $109,752 | 20,553 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $150,255 | 20,360 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $238,596 | 19,983 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $171,219 | 434,567 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $96,038 | 434,567 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $824,460 | 473,828 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $459,530 | 421,588 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $386,205 | 357,598 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $436,645 | 357,907 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $338,587 | 331,949 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $591,691 | 332,411 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $395,494 | 290,805 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $620,361 | 285,881 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $578,859 | 232,474 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $214,166 | 95,185 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $134,569 | 103,515 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $36,617 | 50,858 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $65,606 | 50,858 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $30,565 | 50,859 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||